These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30108834)

  • 21. From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer.
    Zhang CH; Chen K; Jiao Y; Li LL; Li YP; Zhang RJ; Zheng MW; Zhong L; Huang SZ; Song CL; Lin WT; Yang J; Xiang R; Peng B; Han JH; Lu GW; Wei YQ; Yang SY
    J Med Chem; 2016 Nov; 59(21):9788-9805. PubMed ID: 27739679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.
    Sahn JJ; Mejia GL; Ray PR; Martin SF; Price TJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1801-1811. PubMed ID: 28644012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold.
    Yin Y; Chen CJ; Yu RN; Shu L; Zhang TT; Zhang DY
    Bioorg Med Chem; 2019 Apr; 27(8):1562-1576. PubMed ID: 30846405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzimidazolone-based selective σ
    Intagliata S; Alsharif WF; Mesangeau C; Fazio N; Seminerio M; Xu YT; Matsumoto RR; McCurdy CR
    Eur J Med Chem; 2019 Mar; 165():250-257. PubMed ID: 30685525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and adenosine receptor affinity of a series of pyrazolo[3,4-d]pyrimidine analogues of 1-methylisoguanosine.
    Harden FA; Quinn RJ; Scammells PJ
    J Med Chem; 1991 Sep; 34(9):2892-8. PubMed ID: 1895306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model.
    Li GB; Ma S; Yang LL; Ji S; Fang Z; Zhang G; Wang LJ; Zhong JM; Xiong Y; Wang JH; Huang SZ; Li LL; Xiang R; Niu D; Chen YC; Yang SY
    J Med Chem; 2016 Sep; 59(18):8293-305. PubMed ID: 27535613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
    Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
    Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer.
    Zhang CH; Zheng MW; Li YP; Lin XD; Huang M; Zhong L; Li GB; Zhang RJ; Lin WT; Jiao Y; Wu XA; Yang J; Xiang R; Chen LJ; Zhao YL; Cheng W; Wei YQ; Yang SY
    J Med Chem; 2015 May; 58(9):3957-74. PubMed ID: 25835317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.
    Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G
    Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
    Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands.
    Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Bonaccini C; Malmberg Aiello P; Besnard F; Renard S; Costa B; Martini C
    J Med Chem; 2003 Jan; 46(2):310-3. PubMed ID: 12519068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists.
    Redenti S; Ciancetta A; Pastorin G; Cacciari B; Moro S; Spalluto G; Federico S
    Curr Top Med Chem; 2016; 16(28):3224-3257. PubMed ID: 27150365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABA
    Guerrini G; Ciciani G; Daniele S; Di Cesare Mannelli L; Ghelardini C; Martini C; Selleri S
    Bioorg Med Chem; 2017 Mar; 25(6):1901-1906. PubMed ID: 28237554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
    Poulsen SA; Quinn RJ
    J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Mitkin OD; Tkachenko SE; Kysil VM; Okun I
    Eur J Med Chem; 2011 Apr; 46(4):1189-97. PubMed ID: 21333408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
    Somakala K; Tariq S; Amir M
    Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and Structure-Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl-
    Sutherland HS; Choi PJ; Lu GL; Giddens AC; Tong AST; Franzblau SG; Cooper CB; Palmer BD; Denny WA
    Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
    Rahmouni A; Souiei S; Belkacem MA; Romdhane A; Bouajila J; Ben Jannet H
    Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.